190 related articles for article (PubMed ID: 24236034)
21. Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids.
Levy DD; Saijo M; Tanaka K; Kraemer KH
Carcinogenesis; 1995 Jul; 16(7):1557-63. PubMed ID: 7614689
[TBL] [Abstract][Full Text] [Related]
22. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide excision repair activity on DNA damage induced by photoactivated methylene blue.
Berra CM; de Oliveira CS; Garcia CC; Rocha CR; Lerner LK; Lima LC; Baptista Mda S; Menck CF
Free Radic Biol Med; 2013 Aug; 61():343-56. PubMed ID: 23567189
[TBL] [Abstract][Full Text] [Related]
24. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
25. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
26. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.
Khan SG; Levy HL; Legerski R; Quackenbush E; Reardon JT; Emmert S; Sancar A; Li L; Schneider TD; Cleaver JE; Kraemer KH
J Invest Dermatol; 1998 Nov; 111(5):791-6. PubMed ID: 9804340
[TBL] [Abstract][Full Text] [Related]
27. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
[TBL] [Abstract][Full Text] [Related]
29. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
30. XPC beyond nucleotide excision repair and skin cancers.
Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
[TBL] [Abstract][Full Text] [Related]
31. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
32. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
[TBL] [Abstract][Full Text] [Related]
33. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.
Nishi R; Okuda Y; Watanabe E; Mori T; Iwai S; Masutani C; Sugasawa K; Hanaoka F
Mol Cell Biol; 2005 Jul; 25(13):5664-74. PubMed ID: 15964821
[TBL] [Abstract][Full Text] [Related]
34. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.
Sugasawa K; Ng JM; Masutani C; Iwai S; van der Spek PJ; Eker AP; Hanaoka F; Bootsma D; Hoeijmakers JH
Mol Cell; 1998 Aug; 2(2):223-32. PubMed ID: 9734359
[TBL] [Abstract][Full Text] [Related]
35. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
[TBL] [Abstract][Full Text] [Related]
36. XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.
Yurchenko AA; Padioleau I; Matkarimov BT; Soulier J; Sarasin A; Nikolaev S
Nat Commun; 2020 Nov; 11(1):5834. PubMed ID: 33203900
[TBL] [Abstract][Full Text] [Related]
37. Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.
Terunuma A; Ye J; Emmert S; Khan SG; Kraemer KH; Vogel JC
Gene Ther; 2004 Dec; 11(23):1729-34. PubMed ID: 15334113
[TBL] [Abstract][Full Text] [Related]
38. Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells.
Mezzina M; Eveno E; Chevallier-Lagente O; Benoit A; Carreau M; Vermeulen W; Hoeijmakers JH; Stefanini M; Lehmann AR; Weber CA
Carcinogenesis; 1994 Aug; 15(8):1493-8. PubMed ID: 8055625
[TBL] [Abstract][Full Text] [Related]
39. Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells.
Arnould S; Perez C; Cabaniols JP; Smith J; Gouble A; Grizot S; Epinat JC; Duclert A; Duchateau P; Pâques F
J Mol Biol; 2007 Aug; 371(1):49-65. PubMed ID: 17561112
[TBL] [Abstract][Full Text] [Related]
40. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
